Causal Link between n-3 Polyunsaturated Fatty Acid Deficiency and Motivation Deficits.


Journal

Cell metabolism
ISSN: 1932-7420
Titre abrégé: Cell Metab
Pays: United States
ID NLM: 101233170

Informations de publication

Date de publication:
07 04 2020
Historique:
received: 23 04 2019
revised: 02 12 2019
accepted: 13 02 2020
pubmed: 7 3 2020
medline: 4 9 2021
entrez: 7 3 2020
Statut: ppublish

Résumé

Reward-processing impairment is a common symptomatic dimension of several psychiatric disorders. However, whether the underlying pathological mechanisms are common is unknown. Herein, we asked if the decrease in the n-3 polyunsaturated fatty acid (PUFA) lipid species, consistently described in these pathologies, could underlie reward-processing deficits. We show that reduced n-3 PUFA biostatus in mice leads to selective motivational impairments. Electrophysiological recordings revealed increased collateral inhibition of dopamine D2 receptor-expressing medium spiny neurons (D2-MSNs) onto dopamine D1 receptor-expressing MSNs in the nucleus accumbens, a main brain region for the modulation of motivation. Strikingly, transgenically preventing n-3 PUFA deficiency selectively in D2-expressing neurons normalizes MSN collateral inhibition and enhances motivation. These results constitute the first demonstration of a causal link between a behavioral deficit and n-3 PUFA decrease in a discrete neuronal population and suggest that lower n-3 PUFA biostatus in psychopathologies could participate in the etiology of reward-related symptoms.

Identifiants

pubmed: 32142670
pii: S1550-4131(20)30071-1
doi: 10.1016/j.cmet.2020.02.012
pii:
doi:

Substances chimiques

DRD2 protein, mouse 0
Fatty Acids, Omega-3 0
Receptors, Dopamine D2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

755-772.e7

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Fabien Ducrocq (F)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France. Electronic address: fabien.ducrocq1989@gmail.com.

Roman Walle (R)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Andrea Contini (A)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Asma Oummadi (A)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Baptiste Caraballo (B)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Suzanne van der Veldt (S)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Marie-Lou Boyer (ML)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Frank Aby (F)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Tarson Tolentino-Cortez (T)

Research Department, IMG Pharma Biotech S.L., BIC Bizkaia (612), 48160 Derio, Spain.

Jean-Christophe Helbling (JC)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Lucy Martine (L)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, 21000 Dijon, France.

Stéphane Grégoire (S)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, 21000 Dijon, France.

Stéphanie Cabaret (S)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, 21000 Dijon, France.

Sylvie Vancassel (S)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Sophie Layé (S)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Jing Xuan Kang (JX)

Laboratory for Lipid Medicine and Technology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.

Xavier Fioramonti (X)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Olivier Berdeaux (O)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, 21000 Dijon, France.

Gabriel Barreda-Gómez (G)

Research Department, IMG Pharma Biotech S.L., BIC Bizkaia (612), 48160 Derio, Spain.

Elodie Masson (E)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, 21000 Dijon, France.

Guillaume Ferreira (G)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

David W L Ma (DWL)

Department of Human Health and Nutritional Sciences, University of Guelph, 50 Stone Road E., Guelph, ON N1G2W1, Canada.

Clementine Bosch-Bouju (C)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Véronique De Smedt-Peyrusse (V)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France.

Pierre Trifilieff (P)

Université Bordeaux, INRAE, Bordeaux INP, NutriNeuro, 33000, Bordeaux, France. Electronic address: pierre.trifilieff@inrae.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH